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School of Medicine, St. Louis, MissouriABSTRACT A wide range of invasive pathological outcomes originate from the loss of epithelial phenotype and involve either
loss of function or downregulation of transmembrane adhesive receptor complexes, including Ecadherin (Ecad) and binding
partners b-catenin and a-catenin at adherens junctions. Cellular pathways regulating wild-type b-catenin level, or direct muta-
tions in b-catenin that affect the turnover of the protein have been shown to contribute to cancer development, through induction
of uncontrolled proliferation of transformed tumor cells, particularly in colon cancer. Using single-molecule force spectroscopy,
we show that depletion of b-catenin or the prominent cancer-related S45 deletion mutation in b-catenin present in human colon
cancers both weaken tumor intercellular Ecad/Ecad bond strength and diminishes the capacity of specific extracellular matrix
proteins—including collagen I, collagen IV, and laminin V—to modulate intercellular Ecad/Ecad bond strength through a-catenin
and the kinase activity of glycogen synthase kinase 3 (GSK-3b). Thus, in addition to regulating tumor cell proliferation, cancer-
related mutations in b-catenin can influence tumor progression by weakening the adhesion of tumor cells to one another through
reduced individual Ecad/Ecad bond strength and cellular adhesion to specific components of the extracellular matrix and the
basement membrane.INTRODUCTIONDuring developmental processes, such as gastrulation, and
adult pathology, such as cancer metastasis, individual
epithelial/carcinoma cells modulate their mutual interac-
tions in response to the extracellular environmental cues
in a temporal and spatial manner. For example, in the course
of cancer progression from an ordered epithelial layer to
invading carcinoma cells deadhere from adjacent normal
cells and other tumor cells to actively invade through the un-
derlying basement membrane, travel through stromal spaces
by forming short-term adhesions with stromal extracellular
matrix (ECM) proteins, and intravasate between endothelial
cells covering blood vessels and lymphatics to distribute to
and colonize distant organs. Of critical importance in this
metastatic cascade is the nature of the interactions among
invading tumor cells and between these tumor cells and
the other cells and proteins within the ECM that they
encounter on the way.
The biochemical and biophysical stimuli offered by a
tumor microenvironment can favor migrating cells to invade
the stromal space as single cells or collectively (1,2) as
small clusters by forming dynamic associations, which, at
the end of the metastatic cascade subsequently mature at
colonized sites. It is therefore likely that the cells sense
the microenvironment and modulate their intercellular adhe-
sion accordingly.Submitted July 15, 2013, and accepted for publication September 23, 2013.
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0006-3495/13/11/2289/12 $2.00A wide range of invasive pathological outcomes origi-
nate from the loss of epithelial phenotype (3–5) and
involve either loss of function or downregulation of
transmembrane adhesive receptor complexes (6,7). For
example, the complex comprising Ecadherin (Ecad) (8,9)
and its binding partners b-catenin and a-catenin (10,11)
localizes at adherens junctions and modulates the strength
of intercellular adhesion in monolayers of normal cells
and during cancerous processes, such as metastasis.
Cellular pathways regulating the wild-type (WT) b-catenin
level, or direct mutations in b-catenin that affect the
turnover of the protein have been shown to contribute
to cancer development, through induction of uncon-
trolled proliferation of transformed tumor cells par-
ticularly in colon cancer (12,13). However, direct
measurements of alteration in cell-cell adhesion force due
to cancer-related mutations in b-catenin have not been
explored (14).
Here, we show that a cancer-related mutation in b-catenin
present in human colon cancers weakens tumor cell intercel-
lular Ecad/Ecad bond strength and the capacity of tumor
environmental ECM proteins to modulate intercellular
Ecad/Ecad bond strength. Thus, in addition to regulating tu-
mor cell proliferation, cancer-related mutations in b-catenin
can influence tumor progression by weakening tumor cell
adhesion to one another and their microenvironment.
Furthermore, we show that the activity of known b-cate-
nin-related kinase glycogen synthase kinase 3 (GSK3b)
regulates the strength of b-catenin-mediated Ecad/Ecad
bonds in a wide range of cell lines.http://dx.doi.org/10.1016/j.bpj.2013.09.044
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Cell culture
McCoy’s 10A modified medium (GIBCO) was supplemented with 10%
fetal bovine serum (ATCC) and 1% penicillin/streptomycin (Sigma). For
regular culture, cells were plated to 75% confluence in T25 flasks, trypsi-
nized for 2 min at 37C and 5% CO2, resuspended in suspension medium,
and replated in T25 flasks at 1:10 dilution. HBSS buffer was used for all
washing steps. For preparing dishes for single-molecule force spectroscopy,
~10,000 cells were plated into 60 mm culture dishes (either uncoated or
precoated with an ECM molecule) and incubated for up to 2 days to
form small colonies (4–10 cells). Immediately before the experiments, cells
were switched to prewarmed serum-free medium supplemented with
HEPES to maintain pH.Single molecule spectroscopy
Preparing atomic force microscopy (AFM) cantilevers
MSNL-AUHW cantilevers (Veeco, NY) with a nominal force constant of
10 pN/nm were used for all measurements. Cantilevers were gently
washed for 1 min each in 70% ethanol, 10% HCl cleaning buffer, ultra-
pure water, and 95% ethanol. After drying on a clean surface, the cantile-
vers were placed gently for 5 min in a dish containing acetone. The
cantilevers were then either incubated in phosphate buffered saline
(PBS) until ready for experiment or further treated for coating the
surface with ECM molecules. For certain experiments, to let the cells
adhere properly to the surface, 0.5 mg/ml streptavidin was used to coat
the cantilevers.
Coating culture dishes with ECM
Polystyrene culture dishes (Corning, Lowell, MA) were used for coating
various ECM substrates. Briefly, the dishes were washed with ethanol over-
night and allowed to dry in a stream of nitrogen. The dishes were immedi-
ately coated with a solution of specific ECM. 1 ml of 50 mg/ml of human
Collagen IV (Millipore, Billerica, MA), 1 ml of 50 mg/ml of Engelbreth-
Holm-SwarmMatriGel, and 1 ml of 50 mg/ml of human laminin V (Abcam,
Cambridge, MA) solution were used to coat the dishes. For collagen-I, pre-
coated dishes were used (Corning).
Biotinylation of cells for dwell experiments
For experiments requiring a longer contact between cells, biotin was used to
allow the cells to bind strongly to the cantilever, following standard proto-
col (16). Cells were washed thrice with ice-cold PBS and spun down at
1400 rpm for 4 min. Sulfo-NHS-LC-biotin (Thermo-Fisher) was used at
a final concentration of 0.5 mg/ml to incubate the cells at 4C, for
30 min. The biotin-labeled cells were washed thrice with ice-cold PBS, sup-
plemented with glycine to quench the residual biotin, and used immediately
for loading onto AFM cantilevers.
Loading live cells onto AFM cantilevers
An Eppendorf Transjector 5246 (Eppendorf N.A., Hauppauge, NY) was
used to place cells on an AFM cantilever. A cell culture dish con-
taining medium with 2% HEPES added was placed on a TE300
microscope with a 10 Plan-Fluor objective (N.A. 0.3) and a hand-
pulled microneedle was introduced in solution, just over the canti-
lever. Up to 1000 cells were introduced into the solution near to
the end of the cantilever. After the cells settled down at the base of
the dish, the microneedle was used to pick up a few cells, which were
gently placed on the cantilever, while ensuring that the cantilever was
not strained. After the cells were attached, the microneedle was removed
from the solution, an incubation chamber was placed over the dish,
maintaining the cells at 37C and 5% CO2 until they were spread. TheBiophysical Journal 105(10) 2289–2300dish was then placed in a water-heated incubator until the time of
experiment.
Generation of force-displacement curves
A pico-Newton sensitive MFP-1D (Asylum Research, Santa Barbara, CA)
was used to conduct single-molecule force spectroscopy measurements, as
described previously (16–21). Briefly, a cantilever with 1–2 cells attached
to it was introduced into a holder. Bending of the cantilever was measured
by tracking the reflection of a laser beam from the surface of the cantilever.
Postexperiment calibration was also conducted to ensure that the cantilever
did not change its bending rigidity during the experiment. The thermal
resonance method was used to calibrate the force constant of the cantilever
(15) and the photodiode sensitivity was calibrated by impinging the canti-
lever on a hard substrate and measuring the slope of the corresponding
force-displacement curve. Immediately before the experiment, plated cells
were incubated in warm serum-free medium supplemented with 2%
HEPES. Cells were brought in contact for either 1 or 300 ms, and retracted
at a rate of 10 mm/s and the force-distance curves were recorded. No more
than 30% force-displacement curves yielded a bond rupture event, ex-
hibited in the form of a spike and the frequency of occurrence of single,
double, triple, or more than triple bond rupture events was found to
follow Poisson distribution, as expected for bond formation over small
timescales. In order that the cells did not strain too much and the statistical
consistency was maintained, only 30 contacts per cell-pair were allowed
before moving to another cell and the force of impingement was controlled
so that the cells did not press each other beyond what is physiologically
insignificant, in the 50–800 pN range. The integrity of the cells on the
cantilever tip was confirmed both before and after the experiments were
over. Up to four cell-loaded cantilever tips were used for each experiment
to invoke sufficient statistical significance in our results. To negate the
hydrodynamic drag on the cantilever during both descent and ascent
phase, we zeroed the zero-force slope of the force-displacement curve to
obtain the correct loading rate and the rupture force for each bond rupture
event. Because continuous cycling of the piezo through the descent-ascent
cycle sometimes leads to hysteresis, we ensured that the location of the
reflected laser spot on the diode did not deviate from the initial value
by >10% (16–21).Analysis of single-molecule measurements
For each force curve exhibiting a bond rupture, only the last bond
rupture was used for computation of the mean bond strength. This
ensured that any possible intercadherin cooperativity arising as a result
of Ecad cluster formation at the contact site did not affect our
measurement of Ecad/Ecad bond strength because the last Ecad/Ecad
bond ruptured is free of any cooperative influence. The mean bond
strength was obtained for each condition and used for comparison.
To ensure that the rupture event was indeed a single bond rupture
event, the number of instances of a force-curve with none, one, two,
three, or more than three bonds were counted and found to follow a
Poisson distribution, thereby ensuring that most of the events regis-
tered were single bond rupture events. Analysis of individual waves was
done on the IGOR 4.09 platform (Wavemetrics, Lake Oswego, OR)
(16–21).Specificity of measurements
To test that our results indeed represent Ecad-induced adhesion, we carried
out control experiments using antihuman-Ecad function blocking anti-
bodies (HECD-1, Zymed Labs) at a concentration of 200 mg/ml, for which
the cells were allowed to remain incubated at 37C and 5% CO2 for 30 min
before the experiment. Alternatively, chelating agent EDTA was used to
block Ecad-induced adhesion and the corresponding frequency of binding
measured to ensure that bond ruptures observed in the absence of EDTA
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cells (16–21).Depletion of targeting genes with lentiviral-
mediated shRNA
The shRNA sequences targeting the specific genes were selected: mh-b-
catenin shRNA 2501 GGTGCTGACTATCCAGTTGA; mh-a-catenin
shRNA 531 GCTGAAAGTTGTGGAAGAT; mh-GSK3b 1979 GGAA
GCTTGTGCACATTCA; mh-GSK3b 2193 GACCGTGGACAGACC
AATA. The lentiviral vectors containing shRNA cassettes were constructed,
HCT-derived cells were transduced as described (22).Coimmunoprecipitation (CoIP), GST-beads
pulldown, and cell fractionation
Subconfluent culture of HCT116-derived cells in 2X p150 culture dishes
were washed with ice-cold 1XPBS twice, cells were directly lysed in
the dishes with 1 ml of CoIP buffer (20 mM HEPES pH 7.5, 120 mM
NaCl, 5 mM NaF, 1 mM sodium orthovanadate, 0.5 mM EDTA, 0.1%
NP-40, 1 mM DTT, protease inhibitor cocktail from Sigma), collected
with cell lifter, and spun for 10 min at 12,000 rpm, 4C. Protein con-
centrations were determined. 2 mg of cell lysate was used for each
CoIP or pulldown. For CoIP, 2 mg of mouse monoclonal antibody against
b-catenin or mouse IgG were charged to washed protein G sepharose
beads. For pulldown, 2 mg of GST or GST-Ecad-internal cellular domain
fusion protein (plasmid kindly provided by Dr. Cara Gottardi) were
charged to glutathione-agrose beads (both were 20 ml of 1:1 v/v beads
slurry washed with CoIP buffer) at 4C for 1 h, washed with CoIP buffer
three times, incubated with cell lysate for 1 h on a rocker at 4C, and
washed with CoIP buffer five times. 20 ml of sodium dodecyl sulfate-
sample loading buffer was added to each set of washed beads, vortexed,
and boiled for 5 min.
Western blots were performed as indicated. For subcellular fraction-
ation, medium for cells in 2X p150 tissue culture dishes was removed
and cells washed with 30 ml of ice-cold H2O twice. Immediately after
removal of the cold H2O, the plate was tilted for a few seconds to
drain all residue liquid. 0.5 ml of cold hypotonic buffer (20 mM
HEPES pH 7.5, 5 mM NaF, 1 mM sodium orthovanadate, 0.5 mM
EDTA, 1 mM DTT, protease inhibitor cocktail from Sigma) was added;
thereafter, cells were collected with cell lifter (Fisher), transferred to
an Eppendorf tube and passed through a 25 gauge needle with a 1-ml
syringe 30 times to break up the cells. Cell nucleus and mitochondria
fractions were removed by spinning at 8000  g for 10 min at 4C,
the supernatant was transferred to ultracentrifuge tubes, and spun at
100,000  g for 1 h at 4-deg in XL90 Beckmann Ultracentrifuge. The
supernatant was collected as the cytosolic fraction, whereas the pellet
was dissolved in 0.5 ml of cell lysis buffer (hypotonic buffer plus
150 mM NaCl and 0.5% NP-40) for 2 h on ice, vortexed occasionally,
and the mixture was transferred to an Eppendorf tube. After spinning
briefly, the supernatant was collected as the cell membrane fraction. Pro-
tein concentration was determined. For Western blot, 20 mg of proteins
were loaded into each lane.Statistical analysis
Single bond rupture forces were analyzed and compared as mean5 SEM.
Statistical significance was tested following the Michelin grade scale, using
the one-way analysis of variance (ANOVA) nonparametric test with
Bonferroni analysis for multiple comparisons and plotted using commer-
cially available GraphPad Prism software (GraphPad, San Diego, CA).
Values of p < 0.05 were considered significant. For each condition other
than function blocking anti-Ecad antibody control, no less than 140 cleanbond rupture events were analyzed, with a minimum N ¼ 3 independent
experiments.RESULTS
The adhesion strength of single intercellular
Ecad/Ecad bonds is weakened for cells
expressing a cancer-related b-catenin S45
deletion mutant
We first tested the hypothesis that cancer-related mutations
in b-catenin, which are associated with enhanced tumor
growth, can also weaken the strength of interaction between
Ecad molecules on adjoining tumor cells. To do so we
turned to the colon cancer cell line HCT116, which is
heterozygous for the CTNNB1 gene—these cells express
WT b-catenin and b-catenin containing an S45 deletion
(D45). From these parental cells (WT/D45), WT/ and
/D45 cells were generated through homologous recombi-
nation to delete the S45 or WT b-catenin alleles, respec-
tively (23).
The tensile strength of individual Ecad/Ecad bonds
formed between living cells was measured using single-
molecule force spectroscopy (Fig. 1 A). A cell adherent to
a cantilever was placed into contact with a cell placed on
a substrate for a controlled duration, the upper cell was
then retracted at a controlled speed and the strength of indi-
vidual bonds formed during the time of cell-cell contact
measured, as described previously (19). This method allows
us to study individual Ecad/Ecad bonds formed during an
extremely short duration of cell-cell contact (1 ms), without
the confounding effects of an ill-defined number of mole-
cules at the intercellular interface, as in long-term cell-cell
adhesion force measurement assays such as the dual-cell
micropipette assay (24). By keeping the cell-cell contact
force to below half a nano-Newton and allowing bond for-
mation to last for only 1 ms, the assay ensures the formation
of very few (typically less than five) bonds during the dura-
tion of contact. During retraction of the cantilever, the dis-
tance between cells was recorded as a function of time
until complete deadhesion marked by an abrupt decrease
in force (red arrows, Fig. 1 B). A key advantage of this
single-molecule technique is that it is largely insensitive to
the levels of expression of adhesion molecules on cell sur-
faces (16–21), because simultaneous control over the force
of impingement and the duration of contact allows for indi-
vidual bond-rupture events to be registered as separate
events on the force-displacement curve (Fig. 1 B), irrespec-
tive of the number of cell-surface receptors. To test that
single-molecule force spectroscopy measured specific adhe-
sive interactions between Ecad molecules, the plated cells
were incubated with either a function-blocking anti-Ecad
antibody (see Fig. 1 D) or EGTA (Fig. S1 in the Supporting
Material) to deplete calcium in the growth medium. In
both experiments, the frequency of binding between cellsBiophysical Journal 105(10) 2289–2300
FIGURE 1 The regulation of Ecad-mediated
intercellular adhesion at single-molecule resolu-
tion. (A) Schematic of the methodology used to
measure Ecad/Ecad bond strength between
adjoining live cells at single-molecule resolution.
An AFM loaded with living cells is brought into
contact with cells plated on uncoated or ECM-
coated dishes. The cartoon on the right depicts
the central question investigated in this work:
how do changes in intracellular b-catenin and
changes in extracellular ECM affect intercellular
adhesion via modulation of single Ecad/Ecad
bond strength. (B) Representative force-displace-
ment curves obtained during the controlled retrac-
tion of the AFM cantilever at a speed of 20 mm/s.
Red arrows mark bond rupture events; the height
of the fall corresponds to the bond strength ex-
pressed in pico-Newton. Green arrows mark multi-
ple rupture events. Only the last bond rupture was
counted toward the determination of mean bond
strength. (C) Distribution of occurrence of single
and multiple rupture events followed Poisson sta-
tistics, shown for HCT116 cells expressing only
WT (bWT/), only DS45 b-catenin (b/D45), and
with b-catenin depleted (bWT/(KD)). (D) The
frequency of bond rupture with and without func-
tion-blocking antibody, together showing that the
recorded rupture events predominantly reflect the
rupture of Ecad/Ecad bonds. All error bars desig-
nate SEM.
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that appeared on force-displacement curves (red arrows,
Fig. 1 B) were indeed due to the rupture of Ecad/Ecad
bonds. Moreover, the occurrence of bonds formed each
time cells were juxtaposed followed Poison statistics
(Fig. 1 C), as expected for single-molecule force spectros-
copy measurements (25) and further confirms that the
force-spectroscopy measurements were dependent on the
statistical probability of formation of none, one, two, three,
or more than three Ecad/Ecad bonds between apposing
cells, over the short duration of contact. Finally, it was
ensured that the force of impingement and the duration of
contact were chosen such that the frequency of binding
did not exceed ~30% (Fig. 1 D)—thereby ensuring that
>80% of rupture events could be attributed to rupture of
single intercellular bonds—as compared to multiple bond
ruptures occurring simultaneously (16–21,25). Together
these controls ensured that the values of adhesion forces
reported below are specifically the result of single Ecad/
Ecad bonds formed during adhesion between adjoining
cells. Only one type of bond-rupture event was evaluated
because we did not observe multiple peaks in the distribu-
tion of bond rupture forces.(Fig. S2).Biophysical Journal 105(10) 2289–2300Analysis of the distribution of bond strengths obtained by
these single-molecule measurements showed that shRNAi-
mediated depletion of b-catenin in WT/ cells (denoted
b
WT/(KD) cells) resulted in weaker Ecad/Ecad bonds
(i.e., a significantly smaller mean tensile force was required
to break individual bonds between these cells) than those
formed between cells expressing WT b-catenin, as expected
(Fig. 2 A). Surprisingly, cells expressing only the S45
mutant b-catenin (denoted b/D45 cells) formed significantly
weak Ecad/Ecad bonds (Fig. 2 A).
The absence or loss of function of a-catenin has been
shown to correlate with weaker Ecad/Ecad bonds (28,29).
Because a-catenin mediates intercellular adhesion through
its binding to b-catenin, which is bound to the cytoplasmic
tail of Ecad (the Ecad adhesion complex) (28–31), it is not
clear if these results were due to an a-catenin-independent
role played by cancer-related mutant b-catenin or to a loss
of a-catenin binding to the Ecad adhesion complex. To
distinguish between these two scenarios, we expressed an
Ecad-a-catenin chimera protein in cells with b-catenin
shRNAi depleted (denoted bWT/(KD)EC-a) and cells ex-
pressing only mutant b-catenin (denoted b/D45EC-a). Mea-
surements of Ecad/Ecad bond strengths indicated that fusion
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of Ecad was sufficient to rescue Ecad/Ecad bond strength
as compared to Ecad/Ecad bonds formed in mutated or
shRNAi depleted b-catenin backgrounds (Fig. 2 A). More-
over, genetic depletion of a-catenin in cells expressing
WT b-catenin (bWT/-a-cat(KD)) significantly weakened
Ecad/Ecad bonds. Finally, analysis of bond rupture force
distribution using the Hummer-Dudko model (27) showed
that for cells expressing either mutated b-catenin or
shRNAi-depleted of b-catenin, the characteristic bond-tran-
sition length was significantly larger than that measured for
cells expressing either WT b-catenin or Ecad-a-catenin
chimera (Fig. 2 E). Likewise, the free energy of activa-
tion decreased for cells with weaker Ecad/Ecad bonds
(Fig. 2 F). These results are reminiscent of the Ecad/Ecad
bond characteristics exhibited by cells shRNAi-depleted of
a-catenin or expressing mutated a-catenin. These results
are consistent with the model that b-catenin mediates inter-
cellular adhesion through its binding partner a-catenin.
To test whether our results were limited to the two vari-
ants of HCT116 cells examined so far, we used the
following two approaches: First, we measured the native
Ecad/Ecad bond strength of parental HCT116 cells
(bWT/D45) expressing both WTand DS45-mutated b-catenin.
We found that parental cells formed significantly weaker
Ecad/Ecad bonds as compared to (bWT/) cells (Fig. 2 G).
Second, the genetic depletion of b-catenin in these cells
did not exhibit any change in the already weakened Ecad/
Ecad bond strength. Together, these results showed that
b-catenin mutations involved in colon carcinoma not only
affect proliferation, but also affect Ecad/Ecad bond strength
and that S45 deletion mutation in the amino terminal of
b-catenin acts in a dominant negative manner.
Following another approach, we expressed Ecad in
Chinese Hamster Ovary (CHO) which lack endogeneous
Ecad—and expressed Ecad and either endogenous WT
b-catenin or a mix of endogenous WT and exogenous S45
deleted b-catenin (Fig. 2 I). We found that CHO cells
expressing endogenous WT b-catenin exhibited Ecad/Ecad
bonds that were significantly stronger compared to CHO
cells coexpressing WT b-catenin and DS45-mutated b-cate-
nin (Fig. 2 H). Thus, the expression of DS45-mutated
b-catenin alone weakens Ecad/Ecad bonds in a cell-type
independent manner.
It is known that the serine residue 45 on the amino-termi-
nal of b-catenin (S45) is one among four key residues that
are highly conserved across species and are the consensus
GSK3 phosphorylation sites. Because mutations in these
S/T residues are frequent in human colon cancer, we
determined if the deletion of serine 45 residue in parental
colon-carcinoma cells bWT/D45 cells was responsible for
weakening of intercellular Ecad/Ecad bonds. Upon genetic
depletion of GSK3b in parental HCT116 cells (Fig. 2 I),
we observed that although the strength of Ecad/Ecad bonds
was significantly smaller than that for bWT/cells, it wassimilar to the Ecad/Ecad bond strength of parental
HCT116 cells (Fig. 2 H).
Furthermore, to test if the phosphorylation state of b-cat-
enin at S45 indeed mediated Ecad/Ecad bond strength, we
induced phosphomimetic S/D mutation in b-catenin ex-
pressed in CHO cells. We found that the phosphomimetic
mutation (ser to asp) at residue 45 was alone sufficient to
rescue the Ecad/Ecad bond strength to a level similar to
that exhibited by CHO cells expressing only WT b-catenin.
This is in consonance with our earlier result that showed that
S45 residue was necessary to modulate Ecad/Ecad bond
strength.
In summary, even as the presence of mutant S45 in b-cat-
enin in colon cancer cells correlates with increased cell pro-
liferation (22,32), our results suggest that this cancer-related
mutation also plays an additional critical role in cancer pro-
gression—that of weakening individual intercellular Ecad/
Ecad bonds between tumor cells.b-catenin mediates strengthening of single Ecad/
Ecad bond for increasing cell-cell contact time
The absence of a-catenin in the adhesion complex leads to
weakening of Ecad/Ecad bonds over short contact durations,
as opposed to the strengthening exhibited by Ecad/Ecad
bonds formed when a-catenin is present. Because binding
of a-catenin to Ecad is contingent on the presence of b-cat-
enin, we allowed cells to interact for an increased time of
contact and measured the corresponding strength of Ecad/
Ecad bonds for cells expressingWT b-catenin (bWT/), cells
depleted of b-catenin (bWT/(KD)), and cells expressing
S45 mutant b-catenin (b/D45) (Fig. 2 B). Ecad/Ecad bonds
between cells expressing WT b-catenin (bWT/) exhibited
rapid strengthening over just 300 ms, whereas Ecad/Ecad
bonds formed between cells expressing S45 mutant b-cate-
nin (b/D45) exhibited no significant change over the same
time of contact (Fig. 2 B). The depletion of b-catenin in cells
expressing WT b-catenin (bWT/(KD)) weakened Ecad/
Ecad bonds (p ¼ 0.0064, n ~120) (Fig. 2 B). Moreover,
upon juxtaposing cells expressing Ecad-a-catenin chimera
and S45-mutated b-catenin (b/D45EC-a), no weakening of
Ecad/Ecad bonds was observed over just 300 ms.
Together these results indicated that individual Ecad/
Ecad bonds strengthen during nascent intercellular adhe-
sion, a strengthening process mediated by b-catenin and
abrogated in tumor cells expressing mutant b-catenin asso-
ciated with cancer development and progression, or in cells
depleted of b-catenin (summarized in Fig. 2 C). This result
provides further evidence that b-catenin-mediated intercel-
lular adhesion by acting to recruit a-catenin to the Ecad/
b-catenin complex.
Placing the previous results on a pathological footing, we
juxtaposed parental HCT116 cells simultaneously express-
ing both WT and S45 deleted mutant (bWT/D45) and
observed that the mean tensile strength of the resultingBiophysical Journal 105(10) 2289–2300
FIGURE 2 b-catenin modulates the strength of single intercellular Ecad/Ecad bonds. (A) Strength of Ecad/Ecad bonds is significantly weakened in
HCT116 cells expressing only a mutant b-catenin with S45 deleted (b/D45, plain red) and in HCT116 cells wherein b-catenin is knocked down
(bWT/(KD), plain blue) as compared to cells expressing only WT b-catenin (bWT/, plain green). Chimeric fusion of a-catenin to Ecad is sufficient
to rescue the strength of single Ecad/Ecad bonds, (bWT/(KD)EC-a, threaded blue), and (b
/D45
EC-a). Loss of a-catenin leads to significantly weaker
bonds (bWT/-a-cat(KD, light blue). Results depict one-way ANOVA variance analysis using Bonferroni’s multiple comparison test, with *** implying
a ¼ 0.05 (95% confidence intervals). n > 140 for each case; number of independent experiments ¼ 3 or more. (B) Strengthening of single Ecad/Ecad
bonds over time depends on the state of b-catenin. For cells expressing WT b-catenin (bWT/, green bars), Ecad/Ecad bonds strengthened over
300 ms, whereas for cells depleted of b-catenin (blue bars), Ecad/Ecad bonds weakened overt 300 ms (p ¼ 0.0064; n ¼ minimum 140 cells, one-way
ANOVA analysis using Bonferroni’s multiple-comparison test with a ¼ 0.05). Cells expressing Ecad-a-catenin chimera (b/D45EC-a, orange bars), cells
expressing mutant b-catenin (b/D45, red bars), and parental HCT116 cells did not exhibit any time-dependent behavior. (C) Illustration showing the
state of b-catenin when stronger or weaker E-cad/Ecad bonds are formed. (D) Thermodynamic analysis of rupture-force distribution based on the fit
of bond strength distribution by the Hummer-Dudko model (left panel (20),) give rise to computation of transition length (x*) and activation energy
(Ea). Fit shows that (E) transition length increases and (F) free energy of activation decrease significantly for mutated or depleted b-catenin. *** Desig-
nates p < 0.001, unpaired Student’s t-test. A minimum of 140 ruptures were analyzed for each case, with N > 3. (G) In parental HCT116 colon-carcinoma
cells, heterozygous expression of both WT b-catenin and mutated b-catenin leads to weakened Ecad/Ecad bonds between adjoining cells (p ¼ 0.0072;
n >140 cells each, one-way ANOVA analysis using Bonferroni’s multiple-comparison test with a ¼ 0.05). Genetic depletion (shRNAi) of both
b-catenin and known b-catenin kinase GSK3b has the same effect. n.s: not significant. (H) In CHO cells exogenously expressing Ecad, expression of
(legend continued on next page)
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b-Catenin is a Clutch for E-Cadherin Adhesion 2295Ecad/Ecad bonds was significantly lower than the Ecad/
Ecad bonds formed in the presence of WT b-catenin
(Fig. 2 B). Moreover, these cells formed Ecad/Ecad bonds
that did not strengthen over time, in a manner similar to
b-catenin depleted (bWT/(KD) cells or b/D45 cells. These
results therefore suggested that bD45 catenin behaved in a
dominant-negative inhibitory manner upon bWT catenin,
as far as intercellular adhesion is concerned.Binding affinity between Ecad and b-catenin
How then does the S45 mutant b-catenin result in weakened
Ecad/Ecad bond strength between cells? One possibility
could be that the S45 mutant b-catenin does not interact
with the cytoplasmic tail of Ecad or a-catenin as well as
WT b-catenin. As previously reported (23), mutant S45
b-catenin-containing HCT116 cells contain less total
Ecad and cell surface Ecad, but the total cellular level of
b-catenin and a-catenin proteins were unchanged from
WT b-catenin containing HCT116 cells (Fig. 3 A). When
b-catenin was immunoprecipitated, from the various
HCT116 cell lines, the amount of associated Ecad was
equivalent to the relative amount of Ecad detected on West-
ern blots of input lysates from each cell type (Fig. 3 A).
Furthermore, the amount of a-catenin that associated with
immunoprecipitated S45 mutant b-catenin was equal to
that associated with immunoprecipitated WT b-catenin.
Recently, it has been suggested that an interaction between
vinculin and b-catenin is critical for stabilizing Ecad at the
cell surface (33). Because bWT/D45 and b/D45 cells both
have less cell surface localized and total cellular Ecad, we
asked whether this could be explained by an altered interac-
tion between vinculin and mutant b-catenin. In contrast to
what was observed in breast MCF10A cells overexpressing
vinculin, in HCT116 cells expressing an endogenous level
of both vinculin and b-catenin, neither WT b-catenin
nor S45 b-catenin coimmunoprecipitated with vinculin
(Fig. 3 A), and GST-Ecad fusion proteins did not pulldown
vinculin despite the presence of b-catenin (Fig. 3 B).
In another approach we determined the amount of b-cat-
enin and a-catenin that associated with added GST-Ecad
cytoplasmic tail fusion protein, prepared and purified from
bacterial lysates. S45 mutant b-catenin was readily pulled
down (Fig. 3 B). The amount of WT b-catenin pulled
down when GST-Ecad was added to bWT/ HCT116 cell
lysates was much less (Fig. 3 B). This reflected the amount
of available cytoplasmic b-catenin in each cell type as
determined by Western blot analysis of membrane and
cytoplasmic fractions from each cell type (Fig. 3 C). In
bWT/ cells the majority of cellular b-catenin was associatedS45 deletion-mutated b-catenin leads to the formation of weaker Ecad/Ecad
Bonferroni’s multiple-comparison test with a ¼ 0.05), whereas expression of ph
ening of Ecad/Ecad bonds. Immunoprecipitation results (I) exhibit no significan
mutant b-catenin. All error bars designate SEM.with membrane Ecad, whereas in bWT/D45 and b/D45 cells
the amount of cytoplasmic b-catenin was dramatically
increased (Fig. 3 C). Interestingly, and in contrast to b-cat-
enin distribution, the amount and distribution of a-catenin
between cytoplasm and membrane in the three cell types
did not significantly differ (Fig. 3 C). Taken together these
experiments indicated that the S45 mutant b-catenin associ-
ated with the cytoplasmic tail of Ecad and a-catenin as well
as WT b-catenin. Thus, the affinity of S45 mutant b-catenin
for the cytoplasmic tail of Ecad and a-catenin does not
appear to be different from that of WT b-catenin.Tumor cell Ecad/Ecad bond strength is
modulated by cell adhesion to select ECM
proteins and this requires WT b-catenin
In the course of their invasive migration, tumor cells
encounter a host of ECM proteins—collagen IVand laminin
V in the basement membrane and collagen I in the underly-
ing ECM. Therefore, we asked whether interaction of tumor
cells to these different ECM proteins could affect the adhe-
sion strength between Ecad proteins on adjacent cells and
thereby modulate tumor cell invasion and ultimate metas-
tasis. To test this tumor cells were cultured on substrates
coated with relevant ECM proteins for times much longer
than integrin activation time (26, 34). A gradual weakening
of Ecad/Ecad bonds between cells expressing WT b-catenin
(bWT/) occurred as the underlying substrate of cells was
changed from uncoated culture dish, to Matrigel (a mixture
of collagen IV and laminin V), and laminin V (Fig. 4 A). In
contrast, contact of WT b-catenin-expressing cells (bWT/)
plated on collagen I and collagen IV had little influence
on the strength of single Ecad/Ecad bonds compared to un-
coated substrates (Fig. 4 A), at least at short times of cell-cell
contact (1 ms). For cells expressing cancer-related S45
mutant b-catenin (b/D45), there was no change in the
mean bond strength of Ecad/Ecad bonds formed between
cells exposed to any ECM protein studied (Fig. 4 A). In
all the previous measurements, we ensured that the concen-
tration of each of these ligands on the substrate was exactly
the same and the substrate was prepared following identical
conditions, using 1 ml of 50 mg/ml of purified protein solu-
tion in pH 7.2 PBS buffer. Moreover, altering the surface-
density of ECM ligands did not change the mean Ecad/
Ecad bond rupture force, thereby suggesting that our
single-molecular force measurements reflect the stoichiom-
etry-independent, asymptotic effect of ECM ligand on inter-
cellular adhesion.
It was interesting that these results showed that laminin V,
but not collagen IV, induced a sensory response to a changebonds (p ¼ 0.0093; n >140 cells each, one-way ANOVA analysis using
osphomimetic S > D mutated b-catenin induces no significant (n.s.) weak-
t change in Ecad/b-catenin binding affinity in CHO cells expressing DS45
Biophysical Journal 105(10) 2289–2300
FIGURE 3 Affinity of WT and mutant b-catenin
to E-cad remains unaltered. (A) b-catenin mutant
binds to Ecad similarly to WT. Immunoprecipita-
tion was performed using b-catenin antibody or
mouse IgG charged protein G beads and cell
lysates from HCT-derived cells as described in
Methods, Western blotted as indicated. (B). Bacte-
rially ecto-expressed E-cad cytoplasmic tail binds
to b-catenin mutant. Bacterially expressed GST
or GST-Ecad proteins were charged to Gluta-
thione-agrose beads, pulldowns were performed
as described and Western blotted. (C) Less cyto-
solic (lane C) b-catenin in WT/ than in mutant
cells, as compared to membrane-bound b-catenin
(lane M). Cells were fractionated and Western
blotted.
2296 Bajpai et al.in substrate ligand, even though both of these proteins are
abundantly present in the basement membrane. To examine
further the insensitivity to collagen IV, we plated b/D45EC-a,
bWT/(KD), and bWT/(KD)EC-a cells on collagen IV-coated
dishes and measured the corresponding Ecad/Ecad bond
strength during homotypic contact of short duration (1 ms)
(Fig. 4 B). In each case, collagen IV had no significant effect
on the strength on Ecad/Ecad bonds. These results further
confirmed our earlier finding that unlike laminin V, collagen
IV had no effect on the nascent Ecad/Ecad bonds formed
over <1 ms.
In contrast to cell-cell contacts of short duration, increasing
the duration of cell-cell contact to 300ms (Fig. 4C), we found
that collagen IV uniquely weakened the time-dependent
change in Ecad/Ecad bond strength inWT b-catenin contain-
ing cells. WT b-catenin cells plated on laminin V showed no
further weakening of change in Ecad/Ecad bonds overtime,
whereas WT b-catenin cells plated on collagen I showed
normal strengthening of bonds over time (Fig. 4 C). To test
whether b-catenin played a role in matrix protein-mediated
temporal maturation/weakening of Ecad/Ecad bonds, weBiophysical Journal 105(10) 2289–2300plated cells depleted of b-catenin (bWT/(KD)) on collagen
IV-coated culture dishes and measured the mean Ecad/Ecad
bond strength over extended duration of contact (300 ms,
Fig. 4 C). We observed no temporal change in strength of
already weakened Ecad/Ecad bonds (Fig. 4 C), in contrast
to the temporal change in Ecad/Ecad bond strength exhibited
by cells expressing WT b-catenin.
These results allowed us to divide the influence of various
matrix proteins on Ecad/Ecad bond strength into two cate-
gories (Fig. 4 D): a temporal response that reflected a
change in the dynamics of bond maturation and a biochem-
ical response that determined whether the cell can sense
a change in its biochemical extracellular environment.
Collagen I and IV induce similar minimal level of biochem-
ical response, as for both cases, the cells were unable to alter
the strength of immediate Ecad/Ecad bond, going from un-
coated to coated substrates. In contrast, laminin V induces a
significant biochemical response to immediate bond forma-
tion, while not affecting the dynamics of bond maturation,
as suggested by no change in time-dependent bond strength.
Both collagen I and collagen IV affected the temporal
FIGURE 4 Ecad/Ecad bond strength is differentially modulated by cell adhesion to specific ECM molecules through b-catenin. (A) Ecad/Ecad bonds be-
tween HCT116 cells expressing only WT b-catenin (bWT/) or only DS45-mutated b-catenin (b/D45) and plated on substrates coated with different ECM
ligands (Coll. IV – human collagen IV; EHS –Engelbreth-Holm-Swarm MatriGel basement membrane matrix; lam V. – human laminin V; Coll. I – rat-tail
collagen I). Whereas exposure to varied ECM ligands induced change in Ecad/Ecad bond strength in (bWT/) cells, no such response was observed for
b/D45cells. n ¼ minimum 140 cells (N > 3 independent experiments) analyzed with one-way ANOVA using Bonferroni’s multiple-comparison test and
a ¼ 0.05. Unless otherwise marked, all significance is relative to (bWT/) behavior. (B) Collagen IV does not affect single Ecad/Ecad bonds, even when
a-catenin is directly fused to Ecad (bWT/(KD)EC-a and b
/D45
EC-a), mimicking the Ecad/Ecad bonds formed between cells with b-cateninß-catenin depleted
(bWT/(KD). n¼minimum 140 cells (N> 3 independent experiments) analyzed with one-way ANOVA using Bonferroni’s multiple-comparison test and a¼
0.05. (C) Response to increasing duration of cell-cell contact, to 300 ms. Cells expressing WT b-catenin (bWT/) exhibit time-dependent weakening of Ecad/
Ecad bonds when placed on collagen IV, strengthening when plated on collagen I, and no change when coated in laminin V. Cells with depleted (bWT/(KD)
do not show any time-dependent response. ***Designates p < 0.001 under the Michelin grade scale. n ¼ minimum 140 cells (N > 3 independent experi-
ments) analyzed with one-way ANOVA using Bonferroni’s multiple-comparison test and a ¼ 0.05. (D) Illustration showing the different roles played by
different ECM ligands. Although Collagen IVand Collagen I induce a temporal but no sensory response, laminin V induces a sensory response, but no tem-
poral response. Numbers depict the weakening or strengthening of Ecad/Ecad bonds. (E) Similar to bWT/ cells, CHO cells expressing either WT b-catenin or
phosphomimetic S > D mutated b-catenin exhibit significant weakening of Ecad/Ecad bonds upon exposure to laminin V-coated substrate, whereas simul-
taneous expression of WT (endogenous) and DS45-mutated (exogenous) b-catenin induces no laminin V-specific response. All bars designate mean5 SEM,
and n > 140 for each condition.
b-Catenin is a Clutch for E-Cadherin Adhesion 2297maturation of bonds, but in opposite direction (Fig. 3 D).
Another potentially provocative conclusion from these
studies is that matrix proteins abundant in basement mem-
brane (collagen IV, laminin V) inhibited bond strength—
either immediate or temporal maturation, whereas exposure
of cells to the ECM protein collagen I aided the temporal
maturation of Ecad/Ecad bonds, although having no effect
upon the nascent bond strength.
To further test our results in a cell-independentmanner, we
plated CHO cells expressing either WT b-catenin, S45
deleted b-catenin (bDS45), or S/D phosphomimetic b-catenin
(bS45D), on laminin V-coated or uncoated substrates
(Fig. 4 E). We found that the presence of mutated b-catenin
abrogated the substrate-dependent modulation of Ecad/Ecad bond strength, whereas the presence ofWTor phospho-
mimetic b-catenin alone was sufficient to allow for signifi-
cant substrate-dependent Ecad/Ecad bond weakening. This
result again validates our earlier finding that S45 residue on
b-catenin is necessary for modulation of Ecad/Ecad bond
strength.Kinase activity of GSK3b regulates the strength of
Ecad/Ecad bonds but only in the presence of WT
b-catenin
Previous reports have shown that S45 on b-catenin is essen-
tial for priming other downstream b-catenin phosphoryla-
tion sites (27, 35), which together induce cytoplasmicBiophysical Journal 105(10) 2289–2300
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state of b-catenin phosphorylation could endow the cells
with a mechanism by which to control intercellular adhe-
sion, in addition to proliferation. Similarly, several studies
have shown that phosphorylation of Ecad at distinct sites
may induce either an increase or a decrease in affinity for
b-catenin (36–40). Therefore, phosphorylation of adhesion
plaque proteins (Ecad, b-catenin, a-catenin, and to a lesser
extent p120) represent a mechanism by which cells can
modulate their intercellular adhesion. GSK3b is one such
kinase that phosphorylates b-catenin (41) as well as Ecad
(39,42,43). To quantify the effect of phosphorylation on
intercellular adhesion at single-molecule level, GSK3b
was shRNAi-depleted in both WT b-catenin (bWT/) and
mutant b-catenin expressing (b/D45) cells and these cells
were subjected to single-molecule force spectroscopy anal-
ysis (Fig. 5 A). For cells expressing WT b-catenin, when
depleted of GSK3b (GSK3b-KD)bWT/), the strength of a
single intracellular Ecad bond decreased significantly, to a
level similar to mutant b-catenin expressing (b/D45) cells
(Fig. 5 A). The strength of single Ecad/Ecad bonds
in GSK3b depleted cells expressing mutant b-catenin
((GSK3b-KD) b/D45) exhibited no significant change
compared to mutant cells expressing GSK3b (Fig. 5 A).
In another approach testing the role of GSK3b in modu-
lating Ecad/Ecad bond strength, we measured the strength
of Ecad/Ecad bonds formed between cells expressing either
WT (bWT/) or DS45 mutant b-catenin pretreated with
the GSK3b inhibitor LiCl (37, 44). Upon inhibition of
GSK3b, the strength of single Ecad/Ecad bonds decreased
significantly for bWT/ cells, whereas b/D45 cells did not
exhibit any change in Ecad/Ecad bond strength, confirming
our results with GSK3b depleted cells (Fig. 5 A). Together,
these results suggested that the presence of WT b-catenin
was essential for the regulation of intercellular adhesion
by intracellular cues such as GSK3b activity, that are in
turn governed by extracellular cues such as basement
membrane proteins and growth-factors such as the Wnt
factor (43, 45).Biophysical Journal 105(10) 2289–2300To put our studies on a more pathologic footing, we noted
that in the context of colon carcinoma, APC/Axin mutations
are frequent. Because GSK3b associates with the APC/Axin
complex and together, this complex targets b-catenin for
ubiquitination and degradation, we asked if mutations in
any component of this GSK3/APC/Axin complex will
have the same effect on Ecad/Ecad bonds as genetic deletion
of GSK3b. Using SW480 cells that have endogenous colon-
cancer causing APC mutation, we knocked down (Fig. 5 B)
either endogenous b-catenin or GSK3b. We found that
whereas shRNAi depletion of b-catenin induced significant
weakening of Ecad/Ecad bonds, depletion of GSK3b had no
significant effect on the Ecad/Ecad bond strength (Fig. 5 C).
Interestingly, it was also found that parental SW480 cells
form Ecad/Ecad bonds that are as strong as Ecad/Ecad
bonds formed between HCT116 cells expressing only WT
b-catenin (bWT/) but stronger than parental HCT116 cells.
Therefore, it appears that although the actual strength of
Ecad/Ecad bonds varies across cell types, the modulation
of Ecad/Ecad bonds based on phosphorylation state of
b-catenin is conserved and GSK3b is a critical kinase medi-
ating Ecad/Ecad bond strength.DISCUSSION
Examination of all the conditions studied in this work (Figs.
2–4) readily reveals that single Ecad/Ecad bonds display a
consistent low tensile strength basal state under conditions
that induce weakened intercellular adhesion. A variety of
stimuli including intracellular protein modifications, such
as the presence of b-catenin and a-catenin or mutations in
b-catenin, and extracellular cues in the form of changes in
ECM ligands, allow the cell to undergo a molecular-level
decision making process vis-a`-vis intercellular adhesion:
Whether to rapidly enhance or weaken the adhesion strength
of single nascent Ecad/Ecad bond. For increased time of
contact between cells or the type of contact of cells with
various ECM molecules, cells can modulate the tensile
strength of their intercellular Ecad bonds in the presenceFIGURE 5 The kinase activity of GSk3b regu-
lates the strength of Ecad/Ecad bonds but only in
the presence of b-catenin. (A) Upon shRNAi deple-
tion of GSk3b, HCT116 cells expressing WT
b-catenin (GSK3b-KD)bWT/) exhibit significantly
weaker Ecad/Ecad bonds, whereas HCT116 cells
expressing mutant b-catenin (GSk3b-KD)b/D45)
do not show this weakening. Inhibition of GSk3b
(using LiCl, bWT//LiCl and b/DS45/LiCl) also
weakened individual intercellular Ecad/Ecad
bonds. *** Designates p < 0.001, unpaired Stu-
dent’s t-test. (B and C) In SW480 cells with endog-
enous APC mutation, genetic depletion of GSK3b
(B) induces no change in the Ecad/Ecad bond
strength (C), whereas depletion of endogenous
WT b-catenin causes significant weakening of
Ecad/Ecad bonds. All bars designate mean 5
SEM, and n > 140 for each case.
b-Catenin is a Clutch for E-Cadherin Adhesion 2299of WT b-catenin, whereas expression of DS45 b-catenin or
the absence of WT b-catenin abrogates this response.
Because cells as far apart as HCT116 cells, CHO cells
and SW480 cells all exhibit a similar b-catenin-mediated
modulation of single Ecad/Ecad bonds, it is likely that
like Ecad b-catenin also plays a much conserved role in
intercellular adhesion.
These results suggest that for intercellular inside-out
signaling to function properly, the presence of WT b-catenin
is essential. Apart from b-catenin, kinase activity of key
proteins (e.g., GSK3b, CKI, CKII) also governs the robust-
ness of this inside-out signaling. Because a variety of
external cues can modulate the state of b-catenin-related
kinases and phosphatases, it is likely that the net adhesion
state of a cell is a quorum decision involving all external
cues. Although in this work, only the role of substrate
biochemistry is investigated, the role of soluble factors
may be equally as interesting. Specifically, the role played
by Wnt proteins in modulating Ecad/Ecad bond strength
via GSK3b-induced b-catenin processing merits further
investigation.
Extracellular biochemical cues in the form of ligand pre-
sentation can uniquely govern the final mechanical state of
Ecad/Ecad bonds, whereas intracellular conditions such as
the phosphorylation of adhesion-plaque proteins forms the
other level of control over intercellular adhesion. Our results
therefore indicate that b-catenin serves as a clutch that facil-
itates the transition from the low adhesion state of Ecad/
Ecad bond to its strong adhesion state. Moreover, although
genetic fusion of a-catenin to Ecad is enough to strengthen
an intracellular Ecad/Ecad bond, the presence of WT b-cat-
enin is essential for the cell to respond to altered ECM
ligand. Such a stepped control over the strength of Ecad/
Ecad bonds allows the cells to modulate their global inter-
cellular adhesion. Such a scenario is ideal for efficient con-
trol of global intercellular adhesion—both in development
as well as in cancer progression.
Our present results generate several intriguing questions
in understanding intercellular adhesion modulation. The
existence of a single basal level of weak Ecad/Ecad bonds
and multilevel strengthening of Ecad/Ecad bonds suggests
that a simple transition of the Ecad molecule from one
conformation state to another is unlikely. This possibility
is further strengthened by the fact that analysis of crystal
structures of Ecad-b-catenin complexes has not revealed
different stable conformations (46,47).
Our results show that intercellular adhesion at the level of
single Ecad/Ecad bonds is weakened when colorectal cancer
cells (HCT116) that express WT b-catenin were exposed to
laminin V but not collagen IV, which are the major ECM
components of the basement membrane. However, even
though the strength of Ecad/Ecad bonds is weaker when
the cells are plated on reconstituted Engelbreth-Holm-
Swarm and laminin V (as compared to uncoated substrate
or substrate coated with collagen I or collagen IV), it is stillhigher than the basal-level of adhesion. Thus, the regime of
moderate intercellular Ecad/Ecad bonds represents the
optimal regime of regulation of intercellular adhesion:
Ecad/Ecad bonds are strong enough to maintain the integrity
of the epithelial layer and weak enough to allow dynamic
modulation in response to various intercellular adhesion
cues. Also interesting is the fact that colon-carcinoma
derived bWT/ cells (but not b/D45 cells) plated on collagen
I form Ecad/Ecad bonds, which are stronger than Ecad/Ecad
bonds formed by cells plated on proteins that comprise the
basement membrane of epithelial cells. In contrast, it is
known that pancreatic carcinoma cells respond to collagen
I by weakening of adherens junctions (48). Tissue-specific
pathways therefore seem to govern the ultimate response
of cells toward exposure to various ECM substrates.SUPPORTING MATERIAL
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